SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-017230
Filing Date
2020-03-09
Accepted
2020-03-09 16:10:11
Documents
1
Period of Report
2020-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6618
  Complete submission text file 0001209191-20-017230.txt   8032
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Issuer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SPRING BANK PHARMACEUTICALS, INC. 113 CEDAR STREET, STE S-7 MILFORD MA 01757
Business Address
Freve Jonathan (Reporting) CIK: 0001664466 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37718 | Film No.: 20698062